Siemens
Siemens Healthineers Q3 Diagnostics Revenues Almost Double on Rapid Antigen Test Demand
The firm reported total revenues rose 51 percent year over year to €5.00 billion and said full-year 2021 revenues are expected to be up 17 to 19 percent.
The company, which received CE marking for its high sensitivity troponin I assay and Atellica VTLi Patient-side Immunoassay Analyzer, plans to enter the US market.
Blood Collection Firm Babson Diagnostics Raises $31M in Series B Financing
The company said it is working with retail pharmacies to validate its technology and plans to distribute its blood collection system to US pharmacies and retail settings.
Siemens Healthineers Gets FDA Emergency Use Authorization for SARS-CoV-2 Antibody Test
The test runs on the company's Advia Centaur XP, Advia Centaur XPT, and Advia Centaur CP immunoassay systems.
Siemens Healthineers Obtains CE Mark for COVID-19 Rapid Antigen Self-Test
The firm said that its rapid COVID-19 antigen self-test can be used unsupervised by people 12 and older, with or without symptoms, to detect the SARS-CoV-2 virus.